MABVAX THERAPEUTICS (TELK)

2.75
0.25 8.33
OTC
Prev Close 3.00
Open 3.00
Day Low/High 2.75 / 3.00
52 Wk Low/High 1.01 / 16.48
Volume 2.62K
Exchange OTC
Shares Outstanding 1.83M
Market Cap 11.14M
Div & Yield N.A. (N.A)

MabVax Therapeutics Receives Stockholder Approval For Name Change And Reverse Stock Split Resulting From Merger With Telik

Board of Directors Sets Reverse Split Ratio at 8 to 1 and Approves Capital Structure Improvements

3 Stocks Raising The Drugs Industry Higher

TheStreet highlights 3 stocks that pushed the Drugs industry

Why Telik (TELK) Stock Is Soaring Today

Telik (TELK) soared Tuesday after Monday's announcement that the oncology drug development company had entered into a definitive merger agreement with privately held MabVax Therapeutics.

Telik, Biotech Pariah, Finally Died

Telik never recovered from hiding the premature deaths of ovarian cancer patients treated with its experimental drug Telcyta in 2007